Patented Medicine Prices Review Board
-
Canada’s drug pricing conflict sparked by health minister letter, emails showEmails suggest some on the regulator's board believed the crisis that followed the minister's letter threatened the very survival of the agency.PoliticsJun 8, 2023
-
Canada’s health minister denies interfering in agency’s efforts to lower drug costsHealth Minister Jean-Yves Duclos says he has not exercised any undue political pressure on the independent federal agency that regulates the price of patented drugs.HealthApr 27, 2023
-
-
Advertisement
-
Director of Canada’s drug price regulator resigns same week as colleague steps downThe executive director of Canada's drug pricing regulator is stepping down days after another member resigned because of concerns the federal government was undermining their work.HealthFeb 24, 2023
-
-
Advertisement
-
Member of Canada’s drug pricing regulator quits over ‘lack of support’ for medicine cost reformsA member of the Patented Medicine Prices Review Board has resigned over what he calls a 'lack of support' from the federal government and failure to implement reforms.CanadaFeb 23, 2023
-
New drug price rule could save Canada billions, parliamentary budget officer reportsThe new drug pricing regulation, which is set to lower spending on patented drugs, will come into effect in July 1 after being pushed back four times during the pandemic.HealthJun 14, 2022
-
-
Liberals put 6-month pause on efforts to lower cost of patented medicinesHealth Canada first announced in 2019 that the Patented Medicine Prices Review Board (PMPRB) would change how it sets a price cap on medicines in Canada.CanadaDec 23, 2021
-
-
Canada battling pharmaceutical companies over new pricing rules, patients caught in the middleCanada wants to prevent medicines from being "excessively priced," making pharma companies question implementation of life-saving drugs here.CanadaDec 9, 2020
-
Canadian prescription drug prices come under scrutiny of U.S. trade representativeIn its annual report on foreign perils to American rights holders, the office of the U.S. Trade Representative is raising concerns about Canada's plan to recalibrate how it calculates the price of prescription drugs.May 1, 2020
Trending
-
U.S. investors scooping up homes faster than would-be buyers, data shows7,951 Read
-
Denise Richards’ husband files for divorce after 6 years of marriage6,691 Read
-
Trump vows 50% tariff on copper, 200% on pharmaceuticals5,910 Read
-
Amazon Canada Prime Day 2025: 40+ best deals to shop now!5,134 Read
-
‘This is something serious’: Pilots killed in plane crash near Steinbach, Man.2,560 Read
-
Growing number of Canadians view the U.S. as a top threat, poll shows1,757 Read
-
Top Videos
-
Concerns about the growing problem of copper theft127 Viewed
-
House hunting amid economic uncertainty71 Viewed
-
Petition calls for removal of café patio after death of senior who fell43 Viewed
-
Automotive parts manufacturers association doesn’t want countertariffs42 Viewed
-
House hunting amid economic uncertainty
-
Trump vows 50% tariff on copper, 200% on pharmaceuticals
-